ERBB2 and breast cancer: Furthermore, upregulation of gasdermine B (GSDMB), a member of the Gasdermin (GSDM) genes, in HER2 breast cancer promotes poor prognosis, aggressive, and resistant to anti-HER2 agents through elevating protective autophagy.